Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Harry

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunology|December 11, 2007
Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDOCharlotte A Williams, Rachel A Harry, Julie D McLeod
Peptides|May 12, 2009
Nociceptin-induced modulation of human T cell functionKate H Easten, Rachel A Harry, Wendy M Purcell, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritisRachel A Harry, Amy E Anderson, John D Isaacs, et al.
Arthritis and Rheumatism|September 24, 2010
Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responsesJeroen N Stoop, Rachel A Harry, Alexei von Delwig, et al.
Arthritis Research & Therapy|December 21, 2016
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapiesFaye A H Cooles, Amy E Anderson, Tracey Drayton, et al.
Journal of Leukocyte Biology|October 31, 2008
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cellsAmy E Anderson, David J Swan, Bethan L Sayers, et al.
Peerj|September 17, 2016
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapiesPhillip Lord, Rachel Spiering, Juan C Aguillon, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunology|December 11, 2007
Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDOCharlotte A Williams, Rachel A Harry, Julie D McLeod
Peptides|May 12, 2009
Nociceptin-induced modulation of human T cell functionKate H Easten, Rachel A Harry, Wendy M Purcell, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritisRachel A Harry, Amy E Anderson, John D Isaacs, et al.
Arthritis and Rheumatism|September 24, 2010
Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responsesJeroen N Stoop, Rachel A Harry, Alexei von Delwig, et al.
Arthritis Research & Therapy|December 21, 2016
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapiesFaye A H Cooles, Amy E Anderson, Tracey Drayton, et al.
Journal of Leukocyte Biology|October 31, 2008
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cellsAmy E Anderson, David J Swan, Bethan L Sayers, et al.
Peerj|September 17, 2016
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapiesPhillip Lord, Rachel Spiering, Juan C Aguillon, et al.
Pageof 1